NIB still waiting for pandemic-delayed surgeries, profit up
NIB Holdings chief executive Mark Fitzgibbon says the omicron variant kept people from scheduling non-urgent surgeries throughout the six months to December 31 and even into January, after the health insurer delivered a 25 per cent increase in interim net profit to $81.4 million.
NIB increased its interim dividend by 10 per cent to 11¢ a share after premium revenue grew 8.2 per cent, with the pandemic spurring more people to take policies.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Professional services
Fetching latest articles